Neuropharmacology & Neurotherapeutics
Duloxetine is indicated for the treatment of major depressive disorder and for the management of neuropathic pain associated with diabetic peripheral neuropathy. It is also approved for the treatment of fibromyalgia. Most of the adverse events reported in clinical trials of duloxetine were gastrointestinal, neuropsychological, and hepatic.
Mar. 28, 2021